Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Companies

Displaying 1..6 of 6 - per page
Order by
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
BayernPatent offers a wide range of high quality patents from Bavarian universities. More
Aptus Pharmaceuticals, Inc. is a drug discovery company that uses its proprietary technologies to develop therapeutics targeting G-Protein Coupled Receptors (GPCRs). More
The CEI is the technology transfer department of the University of Southampton. We are responsible for IP protection, licenses, spinouts and entrepreneurship throughout the University More
Roche Protein Expression Group provides access to high-value therapeutic targets and peptides! More
Proteomics, in silico protein design More
Displaying 1..6 of 6 - per page
Order by
Partnering consultation free of charge
EuroPLX 39 + 40
Bioiberica
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2009 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us